Browse Bulk hormones topic

Bulk hormones subtopic

Articles

1-78 out of 78 article(s)

Title	Author	Type	Date	Words
Helix BioMedix expands infectious disease and cancer treatment patent estate.		Brief Article	Sep 1, 2002	356
Daiichi obtains United States patent.		Brief Article	Jul 1, 2002	83
ANGSTROM AWARDED FIRST PATENT FOR CANCER TECHNOLOGY PLATFORM.			Oct 1, 1999	377
La Jolla Pharmaceutical Patents Cyclic Peptide Chemistry; Broad Applications for Therapeutic and Diagnostic Product Development.			Sep 29, 1998	714
Micrologix Presents Results Of Its Discovery Research Program At The 38th Annual Interscience Conference On Antimicrobial Agents And Chemotherapy.			Sep 25, 1998	782
GeneMedicine Accelerates Genetic Vaccine Program with Dendritic Cell Targeting.			Aug 18, 1998	649
VIVUS Announces MUSE 18-Month Post-Marketing Safety Data; Over 1 Million Prescriptions and 600,000 Patients Treated, Resulting in Only One Death Reported To FDA.		Article	Jul 22, 1998	588
Ligand Discusses New Compounds That Modulate Androgen Receptor Actions At Endocrine Society Meeting.		Article	Jun 25, 1998	1058
Wyeth-Ayerst Reports the Widespread Use and Reimbursement of CRINONE(R) 8% (progesterone gel)			Jun 10, 1998	1123
Antifungal Peptides Could Protect Cotton	Suszkiw, Jan		Jun 1, 1998	547
U.S. Food and Drug Administration Approves PROMETRIUM(R) (Progesterone, USP) Capsules, Only Oral Formulation of Micronized Progesterone			May 18, 1998	516
Competitive Technologies, Inc. Reports Exclusive Agreement With Palatin Technologies, Inc.			May 14, 1998	796
Ligand Announces Wyeth-Ayerst Submitted IND for Osteoporosis Compound			Mar 26, 1998	592
Sangstat Medical Corp. and Dyax Sign a Research and License Agreement.			Mar 12, 1998	627
REPEAT/Enhance the Dance: Have Better Sex Now.			Feb 12, 1998	610
Gull Laboratories Gains Exclusive EBV License			Jan 20, 1998	458
OrthoLogic Makes Equity Investment in Pioneering Biotech Firm; OrthoLogic Acquires Orthopedic Rights to Promising New Peptide as Part of Deal.			Jan 7, 1998	735
IntraBiotics Announces Manufacturing and Supply Agreements for IB-367.			Dec 4, 1997	296
Hepatology Article Points to Promise of Thymosin Alpha 1 as a Therapy for Hepatitis C			Sep 24, 1997	642
Alteon Contracts with Ganes Chemicals as Bulk Supplier of Pimagedine			Sep 18, 1997	578
United Biomedical Receives Notice of Allowance for Synthetic Luteinizing Hormone Releasing Hormone -- LHRH -- Vaccine.			Aug 27, 1997	255
Wyeth-Ayerst Introduces CRINONE(TM) 8% (progesterone gel), the First and Only Progesterone Cleared by the FDA for Use with Infertility Treatment			May 14, 1997	856
Duramed's Conjugated Estrogens Remains Under Active Review			Feb 11, 1997	221
Synthetech Reports Revenues & Earnings for Third Quarter of Fiscal 1997			Feb 10, 1997	490
Unigene Laboratories Appoints Former Merck Executive To Board			Jan 28, 1997	380
Lilly and TheraTech announce multiproduct peptide delivery development agreement.			Jan 14, 1997	450
The Immune Response Corporation Announces Results From Phase II Clinical Trials for Rheumatoid Arthritis and Psoriasis			Jan 7, 1997	874
Unigene Laboratories Reports Third Quarter 1996 Results			Nov 27, 1996	241
Competitive Technologies, Inc. Reports Patent Issued for Diagnosing And Treating Male Impotence			Nov 26, 1996	403
Supplemental New Drug Application submitted for new, 5 mg Androderm testosterone transdermal "unipatch".			Oct 29, 1996	729
Lilly and Neurocrine Enter Into Collaboration and CoPromotion Agreement for Research and Development Targeting Obesity and Alzheimer's Disease.			Oct 21, 1996	795
Focus on DHEA Spurs Unprecedented Sales Figures			Sep 17, 1996	375
Anergen Receives $2 Million License Fee			Sep 4, 1996	306
Unigene Laboratories Reports Second Quarter 1996 Results			Aug 30, 1996	243
Synthetech Reports Record Revenues & Earnings for First Quarter of Fiscal 1997			Aug 8, 1996	378
Unigene Laboratories Extends Class B Warrant Expiration Date			Aug 7, 1996	130
SIBIA NEUROSCIENCES AND COGNETIX, INC. TO COLLABORATE ON DISCOVERY AND DEVELOPMENT OF CONOPEPTIDE-BASED COMPOUNDS FOR NERVOUS SYSTEM DISORDERS			Jul 26, 1996	507
Allelix - Canadian Scientists Discover Role of Intestinal Growth Hormone New Treatments Now Made Possible for Debilitating Bowel Diseases.			Jul 22, 1996	680
UNIGENE IND ALLOWED BY FDA; PHASE III TRIALS FOR OSTEOPOROSIS PRODUCT TO BEGIN SHORTLY			Jul 16, 1996	332
UNIGENE'S OSTEOPOROSIS PILL EXCEEDS PERFORMANCE Target In All Subjects In Latest Phase 1 Clinical Trial			Jun 25, 1996	380
UNIGENE LABORATORIES REPORTS FIRST QUARTER 1996 RESULTS			Jun 7, 1996	166
Connective Therapeutics announces immune response data from multiple sclerosis t-cell receptor vaccines.			Jun 4, 1996	630
SYNTHETECH REPORTS RECORD REVENUE & EARNINGS FOR FISCAL 1996			May 29, 1996	418
WYETH-AYERST FUNDS $16 MILLION WHI ALZHEIMER'S DISEASE TRIAL STUDYING HORMONE REPLACEMENT THERAPY			May 22, 1996	1001
Columbia Laboratories Announces Results in Phase III Clinical Trials for Crinone That Exceed Expectations; Woman's Well-Being Improves When Natural Progesterone Is Added To Estrogen.			Apr 24, 1996	367
Interfilm, Inc. and RhoMed Incorporated Announce Execution of Merger Agreement.			Apr 12, 1996	333
ARQULE AND BRANDEIS ANNOUNCE SPONSORED RESEARCH AGREEMENT FOR NEW DRUG DISCOVERY			Apr 2, 1996	564
Noven announces U.S. launch of Vivelle; new estrogen skin patch to be sold by Ciba Pharmaceuticals.			Mar 25, 1996	457
SangStat Presents Positive Results on Safety and Biological Activity of ALLOTRAP 2702 in Initial Phase II Trial.			Feb 16, 1996	892
CYTOGEN and ELAN INITIATE RESEARCH AND LICENSING AGREEMENT			Jan 16, 1996	797
UNIGENE SUCCESSFULLY COMPLETES PHASE I TRIAL FOR CALCITONIN PILL			Dec 6, 1995	436
ALPHA 1 BIOMEDICALS SIGNS DEFINITIVE MERGER AGREEMENT			Nov 20, 1995	421
Large-scale trial establishes benefits of long-term management of prostate disease (PART I OF V).			Nov 1, 1995	495
Large-scale trial establishes benefits of long-term management of prostate disease (PART II OF V).			Nov 1, 1995	1365
Large-scale trial establishes benefits of long-term management of prostate disease (PART III OF V).			Nov 1, 1995	1237
Large-scale trial establishes benefits of long-term management of prostate disease (PART IV OF V).			Nov 1, 1995	1633
Large-scale trial establishes benefits of long-term management of prostate disease (PART V OF V).			Nov 1, 1995	1027
XOMA scientist presents new peptide fungicide program at Antifungal Drug Discovery Summit.			Oct 30, 1995	460
Chantal reports first profitable year; Record revenues and earnings achieved in fiscal 1995.			Oct 27, 1995	372
ANALYSES OF PEPTIDE T EFFICACY ON NEUROPSYCHOLOGICAL PERFORMANCE IN HIV SEROPOSITIVE INDIVIDUALS WITH COGNITIVE IMPAIRMENT			Oct 24, 1995	1374
WYETH-AYERST THIRD ANNUAL MENOPAUSE REPORT SHOWS WOMEN LACK KNOWLEDGE ABOUT MENOPAUSAL RISKS AND TREATMENTS			Oct 5, 1995	1529
BARR LABORATORIES, INC. ANNOUNCES ANDA FILING FOR CONJUGATED ESTROGEN			Jul 24, 1995	502
UNIGENE COMPLETES CALCITONIN JOINT VENTURE AGREEMENT FOR CHINA			Jun 26, 1995	463
UNIGENE LABORATORIES BEGINS PRODUCING OSTEOPOROSIS DRUG; GMP STATUS EXPECTED NEXT QUARTER			Jun 22, 1995	415
UNIGENE LABORATORIES EXTENDS CLASS B WARRANT EXPIRATION DATE			Jun 21, 1995	136
SYNTHETECH REPORTS REVENUE, EARNINGS FOR FISCAL 1995			May 26, 1995	313
Chiron and SynPep settle patent suit.			Mar 23, 1995	334
Wyeth-Ayerst Laboratories responds to Families USA.			Mar 15, 1995	540
SYNTHETECH ANNOUNCES FISCAL THIRD QUARTER RESULTS			Feb 10, 1995	414
UNIGENE TO EXPAND OSTEOPOROSIS FOCUS IN COLLABORATION WITH YALE UNIVERSITY SCHOOL OF MEDICINE			Feb 8, 1995	305
Applied Microbiology reports second quarter and half year results.			Feb 7, 1995	693
GeneMedicine announces initial patent issued for its drug-controlled gene-switch technology.			Nov 22, 1994	338
SYNTHETECH ANNOUNCES FISCAL SECOND QUARTER RESULTS			Nov 14, 1994	419
ALPHA 1 BIOMEDICALS, INC. ANNOUNCES CONSUMMATION OF LICENSE AGREEMENT WITH SCICLONE PHARMACEUTICALS, INC.			Oct 7, 1994	335
NOVEL ACTIN-SEQUESTERING PEPTIDE TO BE DEVELOPED BY ALPHA 1 BIOMEDICALS, INC.			Oct 7, 1994	489
PROCYTE PRESENTS NOVEL PROCESSES FOR PEPTIDE MANUFACTURE			Aug 2, 1994	356
NEUROCRINE SCIENTIST HONORED FOR CONTRIBUTIONS TO PEPTIDE HORMONE RESEARCH			Jul 12, 1994	547
SCHERING-PLOUGH LICENSES ORAL ANDROGEN TO SPI PHARMACEUTICALS			Jan 10, 1994	238